ifosfamide has been researched along with Remission, Spontaneous in 15 studies
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ifosfamide, an alkylating agent was used successfully in the treatment of children with steroid sensitive nephrotic syndrome with minimal changes." | 7.65 | [Ifosfamide in the treatment of nephrotic syndrome (author's transl)]. ( Daigeler, C; Gekle, D, 1977) |
| "Ifosfamide, an alkylating agent was used successfully in the treatment of children with steroid sensitive nephrotic syndrome with minimal changes." | 3.65 | [Ifosfamide in the treatment of nephrotic syndrome (author's transl)]. ( Daigeler, C; Gekle, D, 1977) |
| "Seven of the 15 patients with malignant lymphoma responded." | 2.64 | Isophosphamide therapy for hematologic malignancies in patients refractory to prior treatment. ( Bodey, GP; Freireich, EJ; Keating, MJ; McCredie, KB; Rodriguez, V; Valdivieso, M, 1978) |
| " A daily dosage of 50 to 60 mg/kg ifosfamide on 5 consecutive days produced the best results." | 2.64 | Evaluation of a cooperative clinical study of the cytostatic agent ifosfamide. ( Brock, N; Burkert, H; Fichtner, E; Schnitker, J, 1976) |
| "Fifty-six patients with malignant lymphoma of aggressive histologic type (51 large cell, three diffuse undifferentiated, and two nodular mixed) were treated with three non-cross-resistant combination chemotherapy regimens that were introduced sequentially according to the response to therapy." | 1.27 | Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type. ( Bodey, GP; Burgess, MA; Cabanillas, F; Freireich, EJ, 1983) |
| "Ifosfamide was administered to 21 patients with recurrent or disseminated lung cancer at a dose of 4." | 1.26 | Ifosfamide in the treatment of recurrent or disseminated lung cancer: a phase II study of two dose schedules. ( Costanzi, JJ; Gagliano, R; Hokanson, JA; Loukas, D; Panettiere, FJ, 1978) |
| "153 patients with inoperable malignant tumors were treated by the so-called synchronization therapy with vincristine and ifosfamide." | 1.26 | [Clinical experiences with holoxan within the framework of sequential combination therapy (author's transl)]. ( Hartwich, G; Lutz, H; Neidhardt, B, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (86.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yılmaz, S | 1 |
| Özçakar, ZB | 1 |
| Taktak, A | 1 |
| Kiremitçi, S | 1 |
| Ensari, A | 1 |
| Dinçaslan, H | 1 |
| Yalçınkaya, F | 1 |
| Cabanillas, F | 1 |
| Burgess, MA | 1 |
| Bodey, GP | 2 |
| Freireich, EJ | 2 |
| Meyer, T | 1 |
| Ludolph, AC | 1 |
| Münch, C | 1 |
| Costanzi, JJ | 1 |
| Gagliano, R | 1 |
| Loukas, D | 1 |
| Panettiere, FJ | 1 |
| Hokanson, JA | 1 |
| Cohen, MH | 1 |
| Ihde, DC | 1 |
| Bunn, PA | 1 |
| Fossieck, BE | 1 |
| Matthews, MJ | 1 |
| Shackney, SE | 1 |
| Johnston-Early, A | 1 |
| Makuch, R | 1 |
| Minna, JD | 1 |
| Büchner, Th | 1 |
| Kamanabroo, D | 1 |
| Urbanitz, D | 1 |
| Hiddemann, W | 1 |
| van de Loo, J | 1 |
| Rodriguez, V | 1 |
| McCredie, KB | 1 |
| Keating, MJ | 1 |
| Valdivieso, M | 1 |
| Gekle, D | 1 |
| Daigeler, C | 1 |
| Hartwich, G | 1 |
| Neidhardt, B | 1 |
| Lutz, H | 1 |
| Wicart, L | 1 |
| Schnitker, J | 1 |
| Brock, N | 1 |
| Burkert, H | 1 |
| Fichtner, E | 1 |
| von Ardenne, M | 1 |
| Reitnauer, PG | 1 |
| Teufel, G | 1 |
| Pfleiderer, A | 1 |
| Kokron, O | 2 |
| Hoefer, H | 1 |
| Scheef, W | 1 |
| Titscher, R | 1 |
6 trials available for ifosfamide and Remission, Spontaneous
| Article | Year |
|---|---|
Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin | 1979 |
Isophosphamide therapy for hematologic malignancies in patients refractory to prior treatment.
Topics: Acute Disease; Adolescent; Adult; Clinical Trials as Topic; Cyclophosphamide; Drug Resistance; Femal | 1978 |
[Ifosfamide in the treatment of solid tumors and their metastases].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Drug Tolerance; Female; Humans; | 1976 |
Evaluation of a cooperative clinical study of the cytostatic agent ifosfamide.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Breast Neoplasms; Child; Clinical Trials as Topic; Cyclopho | 1976 |
[Treatment of oat cell metastazing bronchial carcinoma with isofosfamide. Results of a prospective randomized study].
Topics: Aged; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Humans; If | 1974 |
[Treatment of bronchogenic cancer and lung metastases of solid tumors with ifosfamid (author's transl)].
Topics: Carcinoma, Bronchogenic; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Female; Humans | 1974 |
9 other studies available for ifosfamide and Remission, Spontaneous
| Article | Year |
|---|---|
Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.
Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Pro | 2016 |
Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclo | 1983 |
Ifosfamide encephalopathy presenting with asterixis.
Topics: Dyskinesia, Drug-Induced; Dyskinesias; Electroencephalography; Humans; Ifosfamide; Magnetic Resonanc | 2002 |
Ifosfamide in the treatment of recurrent or disseminated lung cancer: a phase II study of two dose schedules.
Topics: Adenocarcinoma; Adult; Aged; Bone Marrow; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cyclophos | 1978 |
[Clinical and cell kinetic data on the combination of cytosine arabinoside with daunorubicin, isosfamide, thioguanine, and vincristine for remission induction and maintenance in patients with acute myelocytic leukaemia (author's transl)].
Topics: Adolescent; Adult; Aged; Cell Movement; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Co | 1978 |
[Ifosfamide in the treatment of nephrotic syndrome (author's transl)].
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Female; Humans; Ifosfamide; Infant; Male; Nep | 1977 |
[Clinical experiences with holoxan within the framework of sequential combination therapy (author's transl)].
Topics: Adult; Aged; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Hodgkin Disease; | 1978 |
[Treatment of the DS-carcinosarcoma in the rat with ifosfamide/dimethylsulfoxide].
Topics: Animals; Carcinosarcoma; Cyclophosphamide; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Dru | 1975 |
[Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinomas (author's transl)].
Topics: Cyclophosphamide; Female; Humans; Ifosfamide; Neoplasm Recurrence, Local; Ovarian Neoplasms; Remissi | 1976 |